334 related articles for article (PubMed ID: 24906291)
1. The role of propranolol in the treatment of infantile hemangioma.
Laranjo S; Costa G; Paramés F; Freitas I; Martins JD; Trigo C; Pinto FF
Rev Port Cardiol; 2014 May; 33(5):289-95. PubMed ID: 24906291
[TBL] [Abstract][Full Text] [Related]
2. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
3. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
4. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
6. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of haemangiomas of infancy with propranolol; good results, few side effects].
Hermans DJ; Ottenhof MJ; Wijnen MH; van Beynum IM; van der Horst CM; van der Vleuten CJ
Ned Tijdschr Geneeskd; 2011; 155(40):A3482. PubMed ID: 21988755
[TBL] [Abstract][Full Text] [Related]
8. [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma].
Zhao ZF; Lü RR; Zhang J; Huo R; Xu GQ; Fu HB; Guo X; Wui JC; Lin LL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):174-7. PubMed ID: 21837994
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
10. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events - a review of the literature.
Raphael MF; Breur JM; Vlasveld FA; Elbert NJ; Liem YT; Kon M; Breugem CC; Pasmans SG
Expert Opin Drug Saf; 2016; 15(2):199-214. PubMed ID: 26646657
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.
Castaneda S; Melendez-Lopez S; Garcia E; De la Cruz H; Sanchez-Palacio J
Adv Ther; 2016 Oct; 33(10):1831-1839. PubMed ID: 27461120
[TBL] [Abstract][Full Text] [Related]
16. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
17. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
18. Propranolol for infantile haemangioma: striking effect in the first weeks.
Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
[TBL] [Abstract][Full Text] [Related]
19. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary clinical study on the treatment of severe infantile hemangioma with high-dose propranolol in China].
Zhan MK; Xie YD; Guo ZH; Huang BR; Zhou YK; Chen XS; Li M; Yang YC
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):166-9. PubMed ID: 21837992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
